megestrol acetate has been researched along with HIV Wasting Syndrome in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (65.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, TL | 1 |
| James, JS | 1 |
| Bretón, I; Camblor, M; Cuerda, C; García, P; Miralles, P; Zugasti, A | 1 |
| Auchus, RJ; Benson, CA; Chesney, MA; Egorin, MJ; Liu, T; Mulligan, K; Sattler, FR; Schambelan, M; Shriver, S; Umbleja, T; Von Roenn, JH; Zackin, R | 1 |
| Basgoz, N; Burrows, B; Cannan, J; Corcoran, C; Grinspoon, S; Guccione, A; Heller, H; Hubbard, J; Katznelson, L; Klibanski, A; Lee, K; Walsh, M | 1 |
| Egorin, MJ; Enama, ME; Galetto, G; Li, N; Mayers, J; Timpone, JG; Wright, DJ | 1 |
| Mulligan, K; Muurahainen, N | 1 |
| Carnicero Bujarrabal, M; García Cortés, A; Menéndez Martínez, MA; Pérez Aznar, C; Pérez De Oteyza, C; Torres Léon, JM | 1 |
| Padmanabhan, S; Rosenberg, AS | 1 |
| Carbayo Gorriz, C; Fernández Sánchez, C; López Martínez, G; Marín Gámez, N | 1 |
| Farrar, DJ | 1 |
| Adedokun, A; Clark, RA; Hoffman, M; Kissinger, P; Kopicko, JJ; Momodu, I | 1 |
| Bacsanyi, J; Gibert, C; Koller, E; Malozowski, S; Mann, M | 1 |
| MacDougall, DS | 1 |
| Reiter, GS | 1 |
| Corcoran, C | 1 |
| Cofrancesco, J | 1 |
| Batterham, MJ; Garsia, R | 1 |
| Kira, J; Osoegawa, M | 1 |
4 review(s) available for megestrol acetate and HIV Wasting Syndrome
| Article | Year |
|---|---|
Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; Child; Dietary Supplements; Enteral Nutrition; HIV Infections; HIV Wasting Syndrome; Humans; Megestrol Acetate; Nutrition Disorders; Parenteral Nutrition | 2003 |
Clinical trials update in human immunodeficiency virus wasting.
Topics: Anabolic Agents; Appetite Stimulants; Dietary Supplements; HIV Wasting Syndrome; Humans; Megestrol Acetate; Nandrolone; Nandrolone Decanoate; Randomized Controlled Trials as Topic; Testosterone; Triglycerides | 1998 |
Megestrol acetate: promises and pitfalls.
Topics: Appetite Stimulants; Female; HIV Infections; HIV Wasting Syndrome; Humans; Megestrol Acetate; Weight Loss | 1999 |
[HIV wasting syndrome].
Topics: Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Growth Hormone; HIV Wasting Syndrome; Humans; Megestrol Acetate; Nutritional Support; Testosterone; Thalidomide | 2001 |
3 trial(s) available for megestrol acetate and HIV Wasting Syndrome
| Article | Year |
|---|---|
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Topics: Adult; Androgens; Appetite Stimulants; Body Composition; Double-Blind Method; Drug Therapy, Combination; HIV Wasting Syndrome; Humans; Hydrocortisone; Male; Megestrol Acetate; Middle Aged; Placebos; Protein-Energy Malnutrition; Quality of Life; Sexuality; Testosterone; Treatment Outcome; Weight Loss | 2007 |
The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative.
Topics: Adolescent; Adult; Body Weight; Dronabinol; Drug Therapy, Combination; HIV Wasting Syndrome; Humans; Megestrol Acetate; Middle Aged; Quality of Life | 1997 |
A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
Topics: Adult; Anabolic Agents; Appetite; Counseling; Eating; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Middle Aged; Nandrolone; Nandrolone Decanoate; Prospective Studies; Weight Loss | 2001 |
13 other study(ies) available for megestrol acetate and HIV Wasting Syndrome
| Article | Year |
|---|---|
Involuntary weight loss: interview with Lisa Capaldini, M.D.
Topics: Appetite Stimulants; Body Composition; HIV Wasting Syndrome; Humans; Megestrol Acetate; Oxandrolone; Weight Loss | 2005 |
Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
Topics: Adult; Anabolic Agents; Anthropometry; Appetite Stimulants; Drug Therapy, Combination; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Quality of Life; Safety; Testosterone; Treatment Outcome; Weight Gain | 2005 |
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Topics: Adult; Androgens; Appetite Stimulants; Body Composition; Drug Resistance; Exercise; HIV Wasting Syndrome; Human Growth Hormone; Humans; Hypogonadism; Insulin-Like Growth Factor I; Male; Megestrol Acetate; Middle Aged; Muscles; Nutritional Status; Testosterone; Weight Loss | 1996 |
Megace Oral Suspension for anorexia and cachexia in AIDS.
Topics: Administration, Oral; Appetite Stimulants; HIV Wasting Syndrome; Humans; Megestrol Acetate | 1997 |
[Megestrol in the treatment of AIDS associated cachexia. Evaluation by bioelectric impedance analysis of body composition].
Topics: Adult; Appetite Stimulants; Body Composition; Electric Impedance; Female; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Middle Aged; Progesterone Congeners | 1998 |
Cushing's syndrome induced by megestrol acetate in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Appetite Stimulants; Cushing Syndrome; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate | 1998 |
[Thrombophlebitis by megestrol acetate in patients with human immunodeficiency virus infection].
Topics: Adult; Appetite Stimulants; Female; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Thrombophlebitis | 1998 |
Characteristics of HIV-infected men with low serum testosterone levels.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Candidiasis; Cross-Sectional Studies; Disease Progression; Esophageal Diseases; HIV Infections; HIV Wasting Syndrome; Humans; Longitudinal Studies; Male; Megestrol Acetate; Prognosis; Testosterone | 1999 |
Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Causality; Femur Head Necrosis; HIV Wasting Syndrome; Humans; Magnetic Resonance Imaging; Male; Megestrol Acetate; Middle Aged; Retrospective Studies | 2000 |
Measurement of body composition: the search for a standard.
Topics: Adult; Biomarkers; Body Water; Extracellular Space; Female; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Thalidomide; Treatment Outcome; United States Food and Drug Administration | 1997 |
The HIV wasting syndrome.
Topics: Adipose Tissue; AIDS-Related Opportunistic Infections; Anabolic Agents; Androgens; Anti-HIV Agents; Dronabinol; Female; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Muscles; Neoplasms; Substance-Related Disorders | 1996 |
Approaches to the AIDS Wasting Syndrome.
Topics: AIDS-Related Opportunistic Infections; Anabolic Agents; Appetite Stimulants; Dronabinol; Exercise; Female; HIV Wasting Syndrome; Human Growth Hormone; Humans; Male; Megestrol Acetate; Nutritional Physiological Phenomena; Sex Factors; Testosterone; Thalidomide | 1998 |
Treatment of HIV related weight loss.
Topics: Anabolic Agents; Cannabis; Energy Intake; Exercise Therapy; Female; HIV Wasting Syndrome; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypogonadism; Male; Megestrol Acetate | 1999 |